Ultrasound-Enhancing Agents Market Growth and Analysis by 2031

Historic Data: 2021-2023   |   Base Year: 2023   |   Forecast Period: 2023-2031

Ultrasound-Enhancing Agents Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (First Generation and Second Generation), Application (Abdominal Imaging, Cardiovascular Imaging, Urinary Tract Imaging, and Others), End User (Hospitals, Diagnostic and Imaging Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00039130
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The ultrasound-enhancing agents market forecast is derived on the basis of findings from various secondary and primary research sources. According to The Insight Partners' estimates, the market was valued at US$ 756.61 million in 2023 and is expected to reach US$ 2,511.52 million by 2031; it is estimated to record a CAGR of 16.2% during 2023–2031.

Ultrasound-enhancing agents, also known as ultrasound contrast agents (UCA), are injected to enhance the resolution of images of the organs during an ultrasound scan. These agents consist of suspensions of gas-filled microbubbles smaller than red blood cells and reflect ultrasound signals as they flow through the microcirculation in the blood vessels. They are expelled from the body via urine or bowel movements, within minutes after injection. These agents do not contain any dyes and are considered safe as they pose no known risk of nephrotoxicity.

Factors Driving Ultrasound-Enhancing Agents Market Growth

Ultrasound imaging is currently the first step in estimating the severity of oncological diseases and cardiovascular conditions, paving the way for accurate assessment and diagnosis through further investigation. It is widely used for real-time imaging of body parts for the detection of abnormalities due to the portability, low cost, safety, and diagnostic capabilities of the system. In addition, using contrast agents has significantly improved the sensitivity and specificity of ultrasound for detecting earlier stages of diseases, thus opening up new possibilities for cellular and molecular research in this field. The surging prevalence of chronic diseases such as cancer, kidney diseases, and liver disorders propels the demand for early diagnoses for better management. Their diagnoses necessitate advanced imaging modalities for early detection and health monitoring among diagnosed patients. Ultrasound-enhancing agents enable enhanced visualization of tumors, lesions, and abnormal tissue growth. According to an article published in radiopaedia.org in September 2023, Sonazoid, a contrast agent used in ultrasound imaging, enhances the liver's contrast in the postvascular phase, which can help detect liver tumors, especially those without Kupffer cell metastases. Sonazoid also helps differentiate between regenerative and dysplastic nodules from early-phase hepatocellular carcinomas in a cirrhotic liver. Therefore, the rising adoption of UCAs in diagnostic imaging boosts the ultrasound-enhancing agents market size.

According to an article published in October 2021 by the International Contrast Ultrasound Society (ICUS), 57 original research studies focused solely on pediatric patients, including 4,518 children who underwent 4,906 intravenous contrast-enhanced ultrasound examinations as of August 2021. Additionally, comprehensive protocols developed to evaluate clinical safety demonstrated the highly favorable safety profile of UCAs when used intravenously, intravesically, and through other intracavitary procedures.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Ultrasound-Enhancing Agents Market: Strategic Insights

ultrasound-enhancing-agents-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Report Segmentation and Scope:

The "Global Ultrasound-Enhancing Agents Market Analysis to 2031" is a specialized and in-depth study focusing on the global market dynamics to help identify the key driving factors, future trends, and lucrative opportunities that would, in turn, aid in identifying major revenue pockets. The report aims to provide an overview of the market with detailed market segmentation by type, application, and end user. The geographic scope of the ultrasound-enhancing agents market report entails North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

The ultrasound-enhancing agents market, by type, is bifurcated into the first generation and second generation. The second generation segment held a larger market share in 2023. It is projected to register a higher CAGR from 2023 to 2031.

The market, by application, is segmented into abdominal imaging, cardiovascular imaging, urinary tract imaging, and others. The abdominal imaging segment accounted for the largest ultrasound-enhancing agents market share in 2023. The cardiovascular imaging segment is projected to register the highest CAGR from 2023 to 2031.

Based on end user, the market is segmented into hospitals, diagnostic and imaging centers, and others. The hospitals segment held the largest share of the market in 2023. Further, the diagnostic and imaging centers segment is expected to register the highest CAGR from 2023 to 2031.

Regional Outlook:

North America held the largest ultrasound-enhancing agents market share in 2023. The US dominated the market in this region, in terms of share, followed by Canada. Market growth in the US is attributed to factors such as the presence of major players, including Lantheus Holdings Inc. and GE Healthcare. These companies are increasingly focusing on joint ventures and research collaborations. For instance, GE Healthcare focuses on expanding its product portfolio by launching innovative products and entering strategic partnerships with competitors. In addition, an upsurge in the number of ultrasound procedures due to favorable reimbursement policies supports the ultrasound-enhancing agents market growth in the US.

Industry Developments and Future Opportunities:

As per company press releases, a few initiatives taken by key players operating in the global ultrasound-enhancing agents market are listed below:

  • In March 2024, Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding (MoU) agreement to develop a new area for diagnostic ultrasound devices and contrast agents at the European Congress of Radiology (ECR) 2024, held between February 28 to March 3 in Vienna, Austria. Two companies are considering collaborating to develop high-frequency and super-resolution imaging protocols for diagnosis. The collaboration would also include marketing activities, healthcare providers’ education, and exploration of ultrasound-targeted contrast-enhanced drug delivery technologies with pharmaceutical agents.
  • In April 2023, GE HealthCare launched Pixxoscan (Gadobutrol). It is a macrocyclic, gadolinium-based contrast agent (GBCA) for nonionic magnetic resonance imaging. The product was added to the company’s MRI contrast media portfolio, which includes Claiscan (macrocyclic gadoteric acid) and Rapiscan (used in stress cardiac MR to aid diagnosis of coronary artery disease).

Ultrasound-Enhancing Agents Market Regional Insights

The regional trends and factors influencing the Ultrasound-Enhancing Agents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Ultrasound-Enhancing Agents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

ultrasound-enhancing-agents-market-global-geography
  • Get the Regional Specific Data for Ultrasound-Enhancing Agents Market

Ultrasound-Enhancing Agents Market Report Scope

Report Attribute Details
Market size in 2023 US$ 756.61 Million
Market Size by 2031 US$ 2,511.52 Million
Global CAGR (2023 - 2031) 16.2%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Type
  • First Generation and Second Generation
By Application
  • Abdominal Imaging
  • Cardiovascular Imaging
  • Urinary Tract Imaging
By End User
  • Hospitals
  • Diagnostic and Imaging Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Lantheus Holdings Inc.
  • GE Healthcare
  • Solstice Pharmaceuticals BV
  • FUJIFILM VisualSonics, Inc.
  • Bracco Diagnostics Inc.
  • Bayer AG
  • Vesselon

  • Ultrasound-Enhancing Agents Market Players Density: Understanding Its Impact on Business Dynamics

    The Ultrasound-Enhancing Agents Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Ultrasound-Enhancing Agents Market are:

    1. Lantheus Holdings Inc.
    2. GE Healthcare
    3. Solstice Pharmaceuticals BV
    4. FUJIFILM VisualSonics, Inc.
    5. Bracco Diagnostics Inc.

    Disclaimer: The companies listed above are not ranked in any particular order.


    ultrasound-enhancing-agents-market-cagr

    • Get the Ultrasound-Enhancing Agents Market top key players overview

    Competitive Landscape and Key Companies:

    Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon are among the prominent companies profiled in the ultrasound-enhancing agents market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.


    Frequently Asked Questions

    Who are the major players in the ultrasound-enhancing agents market?

    The ultrasound-enhancing agents market majorly consists of the players, including Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon.

    What are the growth estimates for the ultrasound-enhancing agents market till 2031?

    The ultrasound-enhancing agents market is expected to be valued at US$ 2,511.52 million in 2031.

    Which type segment dominates the ultrasound-enhancing agents market?

    The ultrasound-enhancing agents market is bifurcated into the first generation and second generation. The second generation segment held a larger market share in 2023. It is projected to register a higher CAGR from 2023 to 2031.

    What is ultrasound-enhancing agent?

    Ultrasound-enhancing agents, also known as ultrasound contrast agents (UCA), are injected to enhance the resolution of images of the organs during an ultrasound scan. These agents consist of suspensions of gas-filled microbubbles smaller than red blood cells and reflect ultrasound signals as they flow through the microcirculation in the blood vessels. They are expelled from the body via urine or bowel movements, within minutes after injection. These agents do not contain any dyes and are considered safe as they pose no known risk of nephrotoxicity.

    What was the estimated ultrasound-enhancing agents market size in 2023?

    The ultrasound-enhancing agents informatics was valued at US$ 756.61 million in 2023.

    What factors drive the ultrasound-enhancing agents market?

    Key factors driving the ultrasound-enhancing agents informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for ultrasound-enhancing agents and development.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Ultrasound-Enhancing Agents Market

    1. Lantheus Holdings Inc.
    2. GE Healthcare
    3. Solstice Pharmaceuticals BV
    4. FUJIFILM VisualSonics, Inc.
    5. Bracco Diagnostics Inc.
    6. Bayer AG
    7. Vesselon
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo